Many were surprised to see Bill Belichick, let alone his 24-year-old girlfriend Jordon Hudson, in Dunkin’ Donuts’ commercial ...

NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ ® (upadacitinib), 15 mg, once daily ...

NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily ...

Findings showed 46.4% of patients treated with upadacitinib 15mg achieved sustained remission compared with 29.0% of those who received placebo. The Food and Drug Administration (FDA) has approved ...

This approval positions RINVOQ as the first and only oral Janus Kinase (JAK) inhibitor for GCA treatment in the U.S. The FDA’s decision is supported by the Phase 3 SELECT-GCA clinical trial ...

46.4% on Rinvoq hit sustained remission vs. 29.0% on placebo in Phase 3 giant cell arteritis trial. Rinvoq Q1 sales hit $1.72 billion, rising 57.2% year-over-year. Today's manic market swings are ...

NORTH CHICAGO, Ill. - AbbVie (NYSE:ABBV), a prominent player in the biotechnology industry with a market capitalization of $340 billion, announced today that the U.S. Food and Drug Administration (FDA ...

(RTTNews) - AbbVie (ABBV) Tuesday said the U.S. Food and Drug Administration (FDA) has approved Rinvoq for the treatment of adults with giant cell arteritis (GCA). GCA is an autoimmune disease ...

AbbVie recently secured FDA approval for RINVOQ to treat giant cell arteritis, which alongside a biologics license application for TrenibotE, underscored the company's focus on innovation.

Michelle Pfeiffer is looking back at her earliest acting gig — and how ‘freezing’ her ‘ass off’ in cutoff shorts and a tank ...

In terms of specific figures, Rinvoq sales increased by 57% year-on-year. In addition, the statements made by Jeff Stewart, AbbVie's chief commercial officer, on the Q1 earnings call further ...

Skyrizi sales jumped 70.5% to $3.43 billion, and Rinvoq sales climbed 57.2% to $ ... 1Q25 demonstrated the prowess of AbbVie’s commercial contracting team again, pushing us to again revise ...